“…Our data also revealed reciprocal LOI of the H19 and IGF2 in the majority of heterozygous tumors for both genes and suggest that imprinting of these genes may be a tissue organ-and/or tumor-speci®c process (DeChiara et al, 1991;Jinno et al, 1994;Van Roozendaal et al, 1998;Verkerk et al, 1997). In contrast to studies of Wilms' tumor, sporadic hepatoblastoma and rhabdomyosarcoma (Fukuzawa et al, 1999;Hao et al, 1993;Rainier et al, 1993;Steenman et al, 1994), the presence of biallelic expression of H19 in our study and others (Li et al, 1997;Rachmilewitz et al, 1996;Verkerk et al, 1997) may argue against a tumor suppressor role in favor of an oncogene-like function for this gene (Kim et al, 1998;Li et al, 1997;Mannens et al, 1994). However, the lack of correlation between the expression level of H19 and LOI in some studies suggest that a tumor suppressor function cannot be ruled out (Zhan et al, 1995).…”